BeStock  

Labcorp Holdings LH

US equityMarket cap rank #664Diagnostics & ResearchInfectious DiseaseCRO
$367.13 −$1.75 (-0.47%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $367.13 0.00%
Open$371.48
Prev close$368.88
Day range$366.33 – $372.50
Volume890.6K
Market cap$29.81B
P/E (TTM)30.1
Dividend yield0.78%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$3.81B+6.9% YoY
Operating profit$418.00M+3.9% YoY
Net profit$263.10M+0.6% YoY
Diluted EPS$3.22+3.2% YoY
Free cash flow$412.20M+47.0% YoY
Operating cash flow$563.80M

Revenue, last 8 quarters

$3.3BDec '24$3.3BMar '25$3.5BJun '25$3.6BSep '25$3.5BDec '25$3.5BMar '26$3.7BJun '26$3.8BSep '26

Net profit, last 8 quarters

$143.6MDec '24$213.0MMar '25$238.3MJun '25$261.5MSep '25$164.9MDec '25$278.0MMar '26$299.1MJun '26$263.1MSep '26

Diluted EPS by quarter

1.70Dec '242.52Mar '252.84Jun '253.12Sep '251.98Dec '253.35Mar '263.64Jun '263.22Sep '26

Free cash flow by quarter

$665.1MDec '24$-107.5MMar '25$542.7MJun '25$280.5MSep '25$490.3MDec '25$70.5MMar '26$313.9MJun '26$412.2MSep '26

Annual revenue

$14.0BFY20$13.1BFY21$11.9BFY22$12.2BFY23$13.0BFY24$14.0BFY25

Profitability & balance sheet

Gross margin29.0%
Operating margin11.3%
Net margin6.9%
Return on equity11.4%
Return on assets5.4%
Return on invested capital7.7%
Current ratio1.41
Liabilities / assets53.2%
Cash & investments$261.80M
Total debt$6.59B
Net cash (debt)-$6.33B
Free cash flow / sales8.8%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Diagnostics Laboratories (Dx)$2.95B 77.3%
  • Biopharma Laboratory Services (BLS)$866.70M 22.7%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $3.81B $3.73B $3.54B $13.95B $3.52B
Total Operating Revenue $3.81B $3.73B $3.54B $13.95B $3.52B
Cost of Revenue $2.70B $2.62B $2.52B $9.94B $2.52B
Gross Profit $1.11B $1.11B $1.01B $4.01B $993.20M
Operating Expense $690.10M $655.30M $626.60M $2.50B $610.50M
Selling and Admin Expenses $611.40M $577.20M $551.00M $2.22B $537.90M
Depreciation & Amortization & Depletion $78.70M $78.10M $75.60M $280.00M $72.60M
-Depreciation & Amortization $78.70M $78.10M $75.60M $280.00M $72.60M
Operating Profit $418.00M $456.70M $387.20M $1.52B $382.70M
Net Non-Operating Interest Income (Expense) -$59.10M -$61.10M -$55.10M -$224.10M -$55.00M
Non-Operating Interest Expense $59.10M $61.10M $55.10M $224.10M $55.00M
Other Income (Expense) -$30.90M -$9.20M -$12.40M -$184.60M -$137.10M
Gain on Sale of Security $1.40M $5.60M $12.20M $15.20M $3.50M
Earnings from Equity Interest -$11.00M -$6.20M -$5.10M -$13.30M -$6.10M
Special Income (Charges) -$15.90M -$5.10M -$6.40M -$131.50M -$115.10M
-Less:Restructuring and Mergern & Acquisition $15.90M $5.10M $6.40M $127.20M $110.80M
Other Non-Operating Income (Expenses) -$5.40M -$3.50M -$13.10M -$55.00M -$19.40M
Pretax Profit $328.00M $386.40M $319.70M $1.11B $190.60M
Tax $64.90M $87.30M $41.70M $229.80M $25.70M
Net Profit $263.10M $299.10M $278.00M $877.70M $164.90M
Profit from Continuing Operations $263.10M $299.10M $278.00M $877.70M $164.90M
Minority Interests $300,000.00 $400,000.00 $200,000.00 $1.20M $200,000.00
Net Income to Parent Company $262.80M $298.70M $277.80M $876.50M $164.70M
Net Income to Common Stockholders $262.80M $298.70M $277.80M $876.50M $164.70M
Basic EPS $3.24 $3.66 $3.37 $10.54 $2.00
Diluted EPS $3.22 $3.64 $3.35 $10.46 $1.98
Dividend Per Share $0.72 $0.72 $0.72 $2.88 $0.72
-Less:Impairment of Capital Assets – – – $4.30M $3.60M
Net Income from Discontinuous Operations – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $18.92B $18.53B $19.09B $18.39B $18.39B
Total Current Assets $3.97B $3.81B $4.56B $4.02B $4.02B
Cash and Cash Equivalents & Short-Term Investments $261.80M $141.80M $981.10M $532.30M $532.30M
-Cash and Cash Equivalents $261.80M $141.80M $981.10M $532.30M $532.30M
Receivables $2.56B $2.50B $2.45B $2.26B $2.26B
-Accounts Receivable $2.41B $2.34B $2.29B $2.10B $2.10B
-Other Receivables $145.80M $162.40M $161.90M $156.90M $156.90M
Inventory $538.40M $562.20M $497.70M $534.70M $534.70M
Other Current Assets $607.30M $606.10M $629.50M $692.80M $692.80M
Total Non-Current Assets $14.96B $14.72B $14.53B $14.37B $14.37B
Net PPE $3.14B $3.10B $3.07B $3.08B $3.08B
Investments and Advances $128.30M $139.30M $146.60M $153.90M $153.90M
-Long Term Equity Investment $128.30M $139.30M $146.60M $153.90M $153.90M
Goodwill and Other Intangible Assets $10.89B $10.71B $10.59B $10.39B $10.39B
-Goodwill $7.18B $7.03B $6.96B $6.79B $6.79B
-Other Intangible Assets $3.72B $3.68B $3.64B $3.60B $3.60B
Other Non-Current Assets $793.40M $769.30M $724.90M $751.30M $751.30M
Total Liabilities $10.06B $9.91B $10.34B $9.76B $9.76B
Total Current Liabilities $2.82B $2.12B $2.64B $2.82B $2.82B
Payables $738.00M $688.50M $695.70M $1.00B $1.00B
-Accounts Payable $738.00M $688.50M $695.70M $840.80M $840.80M
Current Accrued Expenses $890.10M $862.40M $851.90M $263.60M $263.60M
Short-Term Debt and Capital Lease Obligation $788.90M $185.90M $688.20M $695.80M $695.80M
-Current Debt $601.20M $900,000.00 $500.40M $500.10M $500.10M
-Current Capital Lease Obligation $187.70M $185.00M $187.80M $195.70M $195.70M
Current Deferred Liabilities $402.60M $387.80M $405.20M $439.10M $439.10M
Total Non-Current Liabilities $7.24B $7.78B $7.70B $6.93B $6.93B
Long Term Debt and Capital Lease Obligation $5.99B $6.58B $6.55B $5.83B $5.83B
-Long Term Debt $5.25B $5.86B $5.83B $5.08B $5.08B
-Long Term Capital Lease Obligation $736.30M $722.60M $718.70M $745.60M $745.60M
Non-Current Deferred Liabilities $528.50M $486.70M $456.40M $605.00M $605.00M
Other Non-Current Liabilities $725.60M $717.60M $691.80M $112.10M $112.10M
Total Equity $8.86B $8.62B $8.75B $8.64B $8.64B
Stockholders' Equity $8.85B $8.61B $8.73B $8.62B $8.62B
Capital Stock $7.30M $7.30M $7.40M $7.50M $7.50M
-Common Stock $7.30M $7.30M $7.40M $7.50M $7.50M
Additional Paid-In Capital $78.70M $0.00 $0.00 $0.00 $0.00
Retained Earnings $8.91B $8.70B $8.78B $8.64B $8.64B
Gains/Losses Not Affecting Retained Earnings -$143.40M -$101.90M -$63.20M -$27.60M -$27.60M
Minority Interests $16.10M $16.40M $16.90M $16.90M $16.90M
-Gross PPE – – – $6.35B $6.35B
-Accumulated Depreciation – – – -$3.27B -$3.27B
-Total Tax Payable – – – $160.30M $160.30M
Derivative Product Liabilities – – – $274.00M $274.00M
Employee Benefits – – – $111.20M $111.20M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $563.80M $445.50M $191.50M $1.64B $614.20M
Net cash flow from continuing operations $563.80M $445.50M $191.50M $1.64B $614.20M
Net Income from Continuing Operations $263.10M $299.10M $278.00M $877.70M $164.90M
Depreciation & Depletion & Amortization $183.00M $179.00M $173.30M $681.10M $173.00M
Deferred Tax $24.40M $24.40M $2.00M $97.60M $21.20M
Other Non-Cash Items $69.00M $63.30M $59.40M $380.10M $178.60M
Change in Working Capital -$6.50M -$155.20M -$352.90M -$526.10M $42.50M
-Change in Receivables -$51.40M -$59.90M -$194.10M -$122.20M $4.30M
-Change in Inventory $25.30M -$65.10M $35.40M -$30.20M -$12.30M
-Change in Prepaid Assets $4.40M $23.10M $4.00M -$25.20M -$41.00M
-Change in Payables and Accrued Expense $5.00M -$35.70M -$166.10M -$383.10M $44.30M
-Change In Other Working Capital $10.20M -$17.60M -$32.10M $34.60M $47.20M
Net cash flow from investing -$433.70M -$366.20M -$322.10M -$1.19B -$389.90M
Net Cash Flow from Continuing Investing Activities -$433.70M -$366.20M -$322.10M -$1.19B -$389.90M
Capital Expenditure -$151.60M -$131.60M -$121.00M -$434.50M -$123.90M
Net Business Purchase and Sale -$272.60M -$236.50M -$208.90M -$575.10M -$71.20M
Net Other Investing Changes -$9.50M $1.90M $7.80M $8.00M -$2.40M
Financing Cash Flow -$10.00M -$919.90M $580.50M -$1.46B -$290.40M
Net Cash Flow from Continuing Financing Activities -$10.00M -$919.90M $580.50M -$1.46B -$290.40M
Net Issuance Payments Of Debt $0.00 -$500.00M $750.00M -$1.00B $0.00
Net Common Stock Issuance $0.00 -$353.80M -$98.00M -$450.00M -$225.00M
Cash Dividends Paid -$58.20M -$58.70M -$61.20M -$240.70M -$59.30M
Proceeds from Stock Option Exercised $49.50M $1.80M $32.90M $54.30M $0.00
Net Other Financing Charges -$1.30M -$9.20M -$43.20M $179.40M -$6.10M
Ending Cash Balance $261.80M $141.80M $981.10M $532.30M $532.30M
Net Change in Cash $120.10M -$840.60M $449.90M -$1.01B -$66.10M
Beginning Cash Balance $141.80M $981.10M $532.30M $1.52B $598.10M
Effect of Exchange Rate Changes -$100,000.00 $1.30M -$1.10M $24.10M $300,000.00
Free Cash Flow $412.20M $313.90M $70.50M $1.21B $490.30M
Cash Flow from Discontinued Operating Activities – – – $0.00 –
Net Investment Purchase and Sale – – – -$192.40M –
Cash Flow from Discontinued Financing Activities – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on LH.

Sign in to join the discussion.

Scroll to Top